ALK-Abelló A/S (OTC:AKBLF – Get Free Report) shares were up 7% during mid-day trading on Monday . The stock traded as high as $22.08 and last traded at $21.72. Approximately 2 shares traded hands during trading, a decline of 100% from the average daily volume of 742 shares. The stock had previously closed at $20.30.
ALK-Abelló A/S Trading Up 7.0 %
The firm has a fifty day moving average of $20.75 and a 200-day moving average of $17.74.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Further Reading
- Five stocks we like better than ALK-Abelló A/S
- The Role Economic Reports Play in a Successful Investment Strategy
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- 3 REITs to Buy and Hold for the Long Term
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Where Do I Find 52-Week Highs and Lows?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
